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Human  basophils  bind IgE  to  their surface membranes  (1,  2)  and  release 
histamine when incubated in vitro with anti-IgE antibodies or with antigen(s) 
to which the surface IgE is directed (3, 4). 
In a previous study it was demonstrated that the surface IgE could be dis- 
tributed  either in  a  uniform diffuse pattern  or in  discrete patches and  polar 
"caps" (2). IgE, detected with an immunoferritin stain, was also observed in 
pinocytotic vesicles under conditions where cap formation was prominent. 
We now report experiments in which the relationship between shifts in the 
distribution of the surface IgE and release of histamine induced by anti-IgE or 
by ragweed  antigen  was  explored.  The  distribution  of cell  surface IgE  was 
assessed by fluorescence microscopy using fluorescein conjugated anti-IgE and 
by  immunoferritin  electronmicroscopy  using  anti-IgG,  antiferritin  hybrid 
antibodies. Histamine release was modulated by varying the concentration of 
anti-IgE or antigen and by varying the conditions of incubation (time, temper- 
ature, presence, or absence of Ca  ++ and Mg  ++);  and the effect of these factors 
on redistribution of surface IgE was studied. 
Materials and Methods 
Call Preparations.--50-60  ml blood was drawn from subjects and diluted two- to fourfold 
with physiological saline and antlcoagulated with 0.01 M EDTA. 8-10 ml portions were layered 
over  3  ml  Ficoll-Hypaque (Pharmacia  Fine Chemicals,  Piscataway, N. J.  and  Winthrop 
Laboratories, New York)  (density 1.077) in a  13  >  125  mm  tube and centrifuged at room 
temperature for 40  rain at  an average of 310-390 g at the interface (5). The interfacial cell 
band (monuclear cell fraction) was aspirated and washed  three times with "Tris  A"  buffer 
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(0.025 M Tris-HC1  pH 7.4, 0.012 M NaCl, 0.005 M  KCI, 0.3 mg/ml human serum albumin). 
Basophils and  total nucleated cells  were counted in a  8peirs-Levy counting chamber by a 
method described  in a previous article (6). In most experiments, 10 ? cells were then suspended 
in 5 ml Tris A buffer containing either 0.01 M EDTA or 0.0006 M Ca  ++ and 0.001 M Mg  ++. 
The desired antibody preparation was added and after suitable incubation periods the cells 
were centrifuged at 230 g and the supernatants saved for histamine analysis. 
Basophils were obtained from both atopic and nonatopic individuals. Leukocytes from most 
individuals released over 50% of total histamine upon exposure to an optimal concentration 
of anti-IgE, but the cells from some donors did not release a significant amount of histamine. 
For  the electronmicroscope studies,  the cells  were incubated with rabbit IgG anti-IgE 
antibody and were then similarly washed two times and incubated at 0°C for 20-30 min with 
20-50 #g  of hybrid  (antlrabbit IgG-antiferritin) antibody. The  cells  were centrifuged and 
suspended in  1 ml buffer containing 0.5 mg ferritin. After 20-30 min at 0°C  the ceils were 
washed two times and fixed with 3% glutaraldehyde in Sorenson's phosphate buffer pH 7.4. 
Fluorescence Microscopy.--Cell  suspensions were dropped on cold slides and a  coverslip 
applied. The slides were then sealed with nail polish. "Ihe ceils were observed either with a 
Leitz Orthoplan microscope (E. Leitz, Inc., Rockleigh, N. J.) equipped with an Osram HB 200 
mercury lamp, BG38 and KP490 exciting filters, darkground condenser and K530 suppression 
filters or with a Leitz Orthoplan microscope equipped with Phloem incident light transmis- 
sion and the same exciting and suppression filters.  Photomicrography was performed using 
Kodak Tri-X (Eastman Kodak Co., Rochester, N. Y.) and exposures of 30-60 s. 
Electronmicroscopy.--After  fixation in glutaraldehyde, the cell  pellets were washed with 
0.25 M sucrose phosphate buffer, fixed in 1% OsO4, dehydrated in ethanol, and embedded in 
Luft's Epon  (Luft Instruments, Inc., Lincoln, Mass.). 60-100  nm sections were cut on an 
LKB "Ultratome" (LKB Instruments, Inc., Rockville, Md.) and the grids stained with 10% 
uranyl acetate in methanol, saturated lead citrate, and then carbon coated. Grids were ex- 
amined on a Hitachi HU11E electron microscope (Hitachi American Ltd., Indianapolis, Ind.). 
Histamine Assays.--The amount of histamine released was measured by the spectrophoto- 
fluorometric technique of Shore (7) as modified by Lichtenstein and Osler (8). 
Sheep Anti-IgE Antibody.--Adult  sheep were immunized sequentially at 3-wk intervals. 
The first two injections consisted of 1 mg purified IgE myeloma protein (PS)  (9) in complete 
Freund's adjuvant injected intramuscularly. The third injection consisted of ~  mg IgE in 
phosphate-buffered saline injected intravenously. Blood  was  collected 7-10  days after the 
last injection and the serum was stored at --70°C. 
10 ml of the whole serum were applied to a  10 ml Sepharose-IgE column containing ap- 
proximately 50 mg of IgE. After incubation for 1 h  at room  temperature  the  column was 
washed extensively with borate buffer.  The bound antibodies were then eluted with 0.1  N 
acetic acid and  the protein eluate neutralized with Tris and  concentrated. Approximately 
100 mg of protein was recovered. This preparation was then applied to a 10 ml Sepharose-IgG 
column equilibrated with borate buffer and containing approximately 50 mg of purified human 
IgG. The protein containing effluent was pooled and reapplied to the same column. The final 
effluent contained about 70 mg of protein. The specificity was checked by using a tanned red 
cell microhemagglutination technique (10). At a  concentration of 8 mg protein/cubic centi- 
meter, the purified anti-IgE gave a  hemagglutination titer of 1:8 against human IgG and 
1 : 80,000 against human IgE. 85%  of this purified protein was specifically  bound when re- 
applied to the IgE immunoabsorbent. 
Rabbit Anti-IgE  Antibody.--Rabbit  anti-IgE  antiserum was obtained by  immunization 
with the Fc fragments of the IgE myeloma protein (PS) included in complete Freund's adju- 
vant (9). The antiserum was absorbed with Bence Jones protein obtained from the myeloma 
patient and with the Fab fragment of the PS protein. The absorbed antiserum did not give a 
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serum was then applied to a Sepharose immunoadsorbent  column coated with the PS myeloma 
protein and the bound antibodies were eluted with glycine-HC1 buffer, pH 3.0. After concen- 
tration,  precipitating  antibody  in  the  purified  antibody preparation was  quantitated  by 
quantitative precipitin analysis using the Fc fragment of the PS myelorna protein as antigen. 
The antibody comprised 70% of total protein in the preparation. 
The specifically  purified antibody was digested with crystalline papain by the method of 
Porter (11). The antibody containing 4.2 mg protein in 2 ml of 0.1  M phosphate buffer,  pH 
7.0, was incubated with 0.04  mg of crystalline papain in the presence of 0.01 cysteine and 
2 mM EDTA. After digestion at 37°C for 6 h, the digestion mixture was applied to a Sephadex 
G100  column  (2  X  30  cm)  to remove undigested  protein. Fractions corresponding to  the 
major 3.5 S  peak were pooled and concentrated. The fragment of anti-IgE and undigested 
antibody were examined for their ability to induce reversed PCA reactions in the monkey (12). 
Normal macaca irus received intracutaneous injections of 0.05 ml of the undigested antibody 
and of the 3.5 S fragment followed by an intravenous injection of Evans blue.  0.02/zN/ml of 
undigested antibody gave definite skin blueing, whereas even 20 #g N/ml of the 3.5 S fraction 
failed to do so. 
Sheep Hybrid A nt#abbit IgG-A ntihorse Ferritin A nlibody.--Separate sheep were immunized 
with purified rabbit IgG and horse ferritin according to the same schedule used for preparing 
anti-IgE sera. The sera were stored at -70°C. 
Antirabbit-IgG was adsorbed onto a  Sepharose rabbit-IgG column containing approxl- 
mately 5 mg IgG per milliliter of Sepharose. After extensive washing with borate buffer the 
bound antibody was eluted with 0.1 N  acetic acid and the eluate neutralized with Tris. Ap- 
proximately 7-8 mg of antibody were recovered per milliliter of sheep serum. 
Antiferritin antibodies were purified in the same way except that the Sepharose-ferritin 
adsorbent contained only 1 mg ferritin per milliliter of Sepharose. Again 7 8 mg of antiferritin 
antibody were recovered from each milliliter of sheep serum. In both cases 93-99% of the pro- 
tein was specifically  bound when small portions were reapplied to the appropriate immuno- 
adsorbent. 
Both antibody preparations were digested with pepsin and the F(ab% fragments recovered 
in the same way in separate experiments (13, 14). 250 mg of protein (10 mg/ml) was dialyzed 
into a 0.15 M Na acetate, 0.05 M NaC1, pH 4.5 buffer. 2% (wt/wt) pepsin was added and the 
solutions incubated at 37°C for 16-18 h. The digestion was stopped by bringing the pH to 8 
with 1 N NaOH. The digestion mixture was next applied to a 590 ml (3.0 X  82 cm) column 
of G150 Sephadex equilibrated with borate buffer.  The main component eluted at approxi- 
mately 50%  bed volume. It gave a strong precipitin line on gel diffusion  against the appro- 
priate  antigen  before but  not after  reduction and  alkylation.  Yields averaged  50%.  The 
F(ab02 fragments of the anti-IgG and antiferritin (at  10 mg/ml)  were mixed and dialyzed 
against 0.1 M Na acetate pH 5.0. The solution was made 0.015 2¢I in mercaptoethylamine and 
incubated for 1 h at 37°C under N'2 • The solution was then applied to a AG50  X  2 ion ex- 
change column (90 ml)  equilibrated with the same Na acetate buffer.  Approximately 70% of 
the applied protein was recovered. The reduced proteins were brought to pH 7.0 with 1 N 
NaOH and gently stirred at room temperature for 2 h under 02. The solution was next applied 
to a 550 ml (3 X  80 cm) column of G100 Sephadex equilibrated with borate buffer. Approxi- 
mately 130 mg of protein eluted at 36% bed volume [F(ab~)2J and 32 mg at 50%  bed volume 
(Fab'). 
One-half of the F (ab')2 material was processed at a time. It was first applied to a Sepharose- 
ferritin column. After washing with borate about 57% of the applied material was recovered 
with the 0.I  N  acetic acid elution. This should have consisted of antiferritin-antiferritin and 
antiferritin-anti-IgG hybrid molecules.  This mixture was applied to a  Sepharose-rabbit IgG 
column and the specifically  bound protein eluted with 0.I  N  acetic acid and neutralized as 
before. This material (9 rag)  precipitated with a mixture of rabbit IgG and ferritin but with 
neither antigen alone.  The overall yield calculated on the basis of the amount of intact anti- 
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Fluorescein Coupled Anti-IgE.--Because  sheep  IgG  does  not  elute  well  from  DEAE- 
cellulose, F(abP)2  fragments were prepared from the specifically purified anti-IgE. The pro- 
cedures were identical to those described under the previous section. The F(ab~)2 fragments 
(45 mg) were applied to a 25 ml column of DEAE-cellulose equilibrated with 0.01 M Na phos- 
phate pH 7.5.85% of the protein was recovered when the column was eluted with 0.01-0.03 M 
phosphate pH 7.5 buffer. The eluate was made 0.075 M in Na2CO~ (pH 9.3) and concentrated 
to 10 mg protein per milliliter. Fluorescein isothiocyanate powder was added to a  final con- 
centration of 0.05 mg/mg protein and the solution incubated at 4°C for 16-18 h. During the 
1st h  the pH was maintained at 9.3 by additions of small amounts of 1 N  NaOH.  The con- 
jugated protein was then dialyzed against 0.01 M phosphate buffer and reapplied to a DEAE- 
cellulose  column  equilibrated  with  the  same  buffer.  Fluorescein-conjugated  protein  was 
eluted  at increasing ionic strengths.  Generally those fractions with a  280  nm:495  nm  ab- 
sorbancy ratio of 0.6-1.7  (representing a fluorescein to protein molar  ratio  of  11-3:1)  were 
used. 
In several experiments intact sheep  anti-IgE  was  fluoresceinated directly and  the  con- 
jugated  protein  adsorbed  onto  DEAE-cellulose.  To  elute  significant  amounts  of  protein 
0.1 M  phosphate,  1 M  NaC1 was required. This protein had a  280 nm:495 nm absorbancy 
ratio of 0.71  (molar ratio 9.5:1).  This material was  then digested with pepsin to give the 
fluoresceinated F(ab~)2 fragments.  No  obvious differences were observed when the alterna- 
tively prepared conjugates were employed. All fluoresceinated fractions retained their ability 
to release histamine. 
For all studies in which Fab  r fragments were used the latter were prepared from fluoresce- 
inated F(ab~)2  fragments.  The divalent fragments were  reduced  with 0.005  M  or  0.01  M 
dithiothreitol in 0.2 M, Tris-HC1, pH 8.6,  incubated for 1 h  at room temperature, alkylated 
with 0.011  M  or 0.022 M  iodoacetic acid and then eluted from G100 Sephadex in order to 
recover the Fab  t fragments. This material was  then concentrated and reapplied twice to a 
G100 Sephadex column. 
A DEAE fraction of otherwise unpurified rabbit anti-IgE was also fluoresceinated as above 
and subsequently purified by adsorption with an IgG-Sepharose column and elution from an 
IgE-Sepharose column. The specificity of this preparation for IgE on basophils was checked 
by  electronmicroscopy using hybrid antirabbit IgG-antiferritin antibodies. Only  basophils 
showed surface bound ferritin. 
Immunoadsorbents.--Protein Sepharose  columns  were  prepared  essentially  as  described 
previously (2,  15). In brief, washed 2B Sepharose was reacted with 300 mg of cyanogen bro- 
mide per milliliter of packed Sepharose at pH 11 and at temperatures below 30°C.  Upon com- 
pletion of the reaction the Sepharose was washed rapidly with 0.1N NaHCO~  (pH  8.5)  and 
then incubated with 5 mg protein per milliliter Sepharose at 4°C for 16-18 h. When ferritin 
was  coupled only  1 mg protein per milliliter of  Sepharose was  used  because  the coupling 
efficiency of this protein is low in our experience (2). Approximately 90-99% of applied protein 
was bound to the Sepharose. The columns were equilibrated with borate buffer and kept at 
4°C when not in use. 
Miscdlaneous.--Rabbit  IgG (Cohn Fraction II, Pentex Biochemical, Kankakee, Ill.) was 
purified  on  DEAE-cellulose.  Horse  ferritin  (six  times  recrystallized,  Pentex)  was  used  as 
such.  Fluorescein isothiocyanate was  obtained from  Sigma  Chemical  Co.,  St.  Louis,  Mo., 
crystalline papain from Mann Research Labs Inc., New York and pepsin from Worthington 
Biochemical Corp., Freehold, N. J. Purified ragweed antigen (Fr IV-C, antigen E) was kindly 
supplied by Dr. M. Chase, The Rockefeller University, New York. 
RESULTS 
Characteristics of Cell Preparations.--When  reacted with Trypan Blue 95 % 
or more of the cells excluded the dye. By toluidine blue staining (6)  approxi- 
mately 2-3 % of the cells demonstrated typical basophilic granules. By Wright's 398  SURFACE  IgE  DURING  HISTAMINE  RELEASE 
stain the differential count showed 2-3 oJ/0 basophils, 5-20% monocytes, and the 
rest lymphocytes. 
Specificity  of Reagenls.--When  treated with  any of the fluorescent anti-IgE 
preparations, the percentage of stained cells agreed well with the percentage of 
basophils estimated by toluidine blue staining. In one experiment cells were first 
reacted  with  Fab' fragments of fluoresceinated  rabbit  anti-IgE.  The washed 
cells  were  then  sequentially  reacted  with  sheep  antirabbit  IgG-antiferritin 
hybrid antibody and  ferritin.  By electronmicroscopy ferritin staining was ob- 
served only on basophils. Sinfilarly when unfluoresceinated rabbit anti-IgE was 
used in the first step only basophils showed ferritin staining. 
I~ffect of Monovalenl Anti-IgE on the Distribution of Cell Surface IgE.--Cells 
were reacted  with  the  Fab' fragments of fluoresceinated sheep anti-IgE. The 
cells exhibited diffuse staining of the surface membrane at most doses of anti- 
body  employed  (0.1-12 #g/ml).  With  24 #g/ml  and  a  90  rain  incubation  at 
37°C,  about  one-third  of  the  fluorescent  cells  showed  several  more intensely 
stained  spots which were small and discrete.  Still  only about 2 %  of the  total 
cells were stained. 
When basophils were observed in  the electronmicroscope after having been 
incubated sequentially with Fab fragments of rabbit anti-IgE, hybrid antibody, 
and ferritin,  the basophils had a diffuse pattern of labeling with ferritin scat- 
tered  lightly  in  a  more  or  less  continuous  pattern  over the  cell  membrane. 
Capping was not seen. (See Figs. 1 and 2, top row.) 
Studies with Divalent  Anti-IgE.  Aliquots  of  the mononuclear  cell  fraction 
from each individual were incubated with various concentrations of fluorescein 
coupled anti-IgE for 30 min to 240 rain at 37°C. These results are summarized 
in Table I. Basophils from two individuals shown in Table I  did not release a 
significant amount of histamine at any of the anti-IgE concentrations  tested. 
However, cells from all subjects exhibited the same dose and time dependence 
in  their fluorescent staining patterns.  Also,  the percentage of fluorescent cells 
agreed well  with  the  percentage of basophils  estimated  from the  differential 
counts. 
Low  doses:  When  cells  were  incubated  with  0.03-0.2 ~,g/ml  of  fluores- 
ceinated divalent F(ab')e fragments of sheep anti-IgE for 30 to 90 min, a  dif- 
fuse  staining  pattern  was  observed  (Fig.  1,  first  row).  In  most  cases  the 
circumference  was  continuously  fluorescent  with  no  evident  heterogeneity. 
About  10%  of the  stained cells exhibited several areas with more intense fluo- 
rescence. The overall  appearance of the  cells was indistinguishable  from that 
observed  with  the  monovalent  Fab'  fragments.  Photomicroscopy  of  cells 
stained  diffuseh- with  these  low doses  of anti-IgE was  unsatisfactory  due  to 
weak fluorescence. 
Cells  incubated  for 31/,~ to 4  h  at  37°C  with  sheep  antibody showed some 
patching and capping. Those cells which still showed diffuse staining more often 
had discrete intensely fluorescent spots superimposed on a diffuse background. l"m.  1.  Section of human basophil reacted with Fab fragments of rabbit anti-IgE, hybrid 
antibcdy, and ferritin at 37°C.  Bound ferritin is distributed diffusely, and extensively along 
the cell membrane. Magnification X  40,000. 
399 TABLE  I 
Histamine Release and Cell Surface  IgE Distribution  with Divalent A nti-IgE 
Histamine  Subject  Conc.  a-IgE  Time  release 
Staining pattern 
Diffuse  Patchy  Caps  Internal 
P.  G. 
B.W. 
J.A. 
A.[K. 
K. B. 
~g/ml  m.i~  % 
0.028  30  35  Too hight  to determine 
0.14  15  73  96  4  0  0 
0.14"  30  74  -4-  3  98  4-  1  2  -4-  1  0  0 
0.14  90  70  96  4  0  0 
0.14  220  70  46  24  30  1 
0,28  30  ND  94  6  0  0 
0.56  30  73  90  9  1  0 
1.4  10  32  45  55  0  0 
1.4~  30  44  4-  8  8  4-  1  75  4-  6  17  -t-  7  0 
1.4  90  47  0  38  46  17 
1.4  220  50  0  6  86  9 
14.0§  30  10  4-  10  2  4-  2  38  4-  11  59  4-  10  0 
14.0  90  10  0  15  66  19 
14.0  220  11  0  4  82  14 
140  30  4  2  36  62  ND 
0.005  30  4  Too light to determine 
0. 010  30  10  Too light to determine 
0.05  30  33  99  1  0  0 
0.10  30  48  95  5  0  0 
0.50  30  68  68  31  1  0 
1.0  30  52  8  75  17  0 
10.0  30  30  1  16  70  13 
100  30  11  0  7  45  48 
0.057  30  68  100  0  0  0 
0.14  30  60  100  0  0  0 
1.4  30  36  0  83  17  0 
14.0  30  10  0  36  61  3 
0.058  30  <10  100  0  0  0 
0.11  30  < 10  100  0  0  0 
0.11  90  < 10  97  3  0  0 
0.11  240  <10  50  38  12  0 
0.14  30  < 10  95  5  0  0 
0.58  30  <10  73  19  2  1 
1.1  30  <10  30  45  18  7 
1.1  90  <10  0  29  49  22 
1,1  240  <10  2  15  53  31 
1.4  30  <10  1  67  28  2 
2.8  30  <10  0  59  38  3 
11.0  30  <10  0  38  40  22 
11.0  90  <10  0  9  80  11 
11.0  240  <10  0  14  50  36 
14.0  30  <10  0  42  58  0 
0.14  30  <10  94  4  0  0 
1.4  30  <10  4  62  29  5 
12.0  15  <10  0  25  69  6 
12.0  30  <10  0  17  59  25 
12.0  60  <10  0  12  64  24 
12.0  240  <10  0  5  79  15 
14.0  30  <10  1  23  63  8 
ND, Not determined. 
* Average and range of values from two separate experiments. 
:~ Average and range of values from three separate experiments. 
§ Average and  range of values from four separate experiments. 
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Cells reacted with 0.1-0.3  /~g/ml of rabbit anti-IgE and subsequently treated 
with hybrid antibody and ferritin showed little or no labeling when examined 
by etectronmicroscopy. 
Intermediate doses:  Cells incubated with 1-2/zg/ml of fluoresceinated sheep 
anti-IgE for 30 rain at 37°C showed a patchy staining pattern (Fig. 2, second 
row). By electronmicroscopy appropriately treated cells also showed a patchy 
distribution of the ferritin. Pinocytotic vesicles  containing  ferritin were  ob- 
served. Cells incubated for longer times showed a shift in the staining pattern 
from patch to cap formation and obvious internalization. 
High doses:  When cells were incubated at37°C for 30 rain with 10-100 #g/ml 
of  fluoresceinated  sheep  anti-IgE,  the  labeled  antibody  was  observed  pre- 
dominantly at one end of the cell covering less than 1/~ of the cell circumference 
(Fig. 2, third row). Increased internalization was observed with cells incubated 
for longer times (11/~-4 h) and the total fluorescence per basophil appeared to 
be somewhat reduced. Such cells showed little or no surface staining but only 
multiple small round areas of cytoplasmic fluorescence. By electronmicroscopy 
capping  and  extensive  staining  of pinocytotic vesicles  was  observed in  ap- 
propriately treated cells (Fig. 3). Even at these high doses only basophils were 
labeled. 
In  some  experiments,  cells  were  reacted  with  fluoresceinated anti-IgE  in 
0.01 M Tris-EDTA buffer, a buffer in which histamine release is inhibited. The 
presence or absence of divalent cations had no effect on the redistribution of the 
surface IgE. The effect of temperature during incubation on the distribution 
was also tested. Representative results are shown in Table II. Cells incubated 
with high doses of anti-IgE at 0°C for 30 rain showed some patchy staining; 
at lower doses, the staining pattern was diffuse. 
Correlation of Histamine Release with Distribution  of Cell Surface IgE.-- 
Monovalent anti-IgE:  Cells  from sensitive individuals were incubated with 
varying amounts  of monovalent anti-IgE  (Fab  or Fab'  fragments)  at 37°C. 
Histamine release was always 2 % or less at anti-IgE concentrations of 2/~g/ml 
or less. At higher doses (10 or 24 #g/ml) some histamine release was observed. 
In  a  separate  experiment, Fab ~ fragments which had been refractionated on 
G100 Sephadex several times produced progressively lower histamine release. 
Indeed, after three fractionations the central portion of the effluent peak gave 
no histamine release at 4/zg/ml, whereas bivalent F(ab')2 gave maximal release 
(68 %) with a concentration of 0.04 #g/ml. 
Divalent  anti-IgE:  Cells  from  sensitive  individuals  were  incubated  with 
varying amounts of divalent anti-IgE in  the presence of Ca  ++  and  Mg  ++  at 
37°C for 30 min. Maximal histamine release occurred with low concentrations 
of  anti-IgE  (0.03-0.2/zg/ml).  When  cells were  incubated  with  intermediate 
doses  of fluorescent anti-IgE  (1-2 gg/ml),  suboptimal  histamine  release  oc- 
curred.  With  high  doses  of  anti-IgE  (10-100 ~g/ml)  more  or  less  complete 
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results of previous studies  (16). At all doses, histamine  release was essentially 
complete  within  30  min  with  no  additional  release  even  after  220  min.  The 
relationship  between  the  dose  response  curve  for  histamine  release  and  for 
redistribution of surface IgE for one subject is shown in Fig. 4. 
Cell Surface  IgE Distribution  with Antigen Induced Histamine Release.--In 
these  experiments,  cells  from  subjects  sensitive  to  ragweed  antigen  E  were 
incubated with a concentration of antigen giving maximal histamine release or 
with 500--1,000 times excess antigen.  After washing,  the  cells were then incu- 
bated with fluoresceinated Fab' fragments of sheep anti-IgE or with unfluores- 
ceinated  rabbit  Fab fragments,  hybrid antibody and ferritin.  In all instances, 
the cells  showed uniform diffuse surface staining.  The presence  or absence  of 
Ca  ++ and  Mg  ++ and incubations  at 0°C and  at 37°C produced no detectable 
differences in the IgE distribution.  These results are summarized in Table III. 
DISCUSSION 
In  this  stud)"  we  have  extended  previous  investigations  on  those  factors 
which influence  the surface distribution  of IgE on human basophils and have 
studied  the  relationship  between  changes  induced  in  the  surface  distribution 
and histamine release. 
It was previously shown that with 50 #g/ml of divalent anti-IgE, capping of 
the  surface IgE occurred at room temperature  and  at 37°C  but  that capping 
was inhibited more or less completely at 0-4°C (2). In the present work we have 
found  that  the  degree  of patch  or cap  formation  was  highly dose,  time  and 
teml;erature  dependent.  At low doses of anti-IgE no gross redistribution  was 
observed.  At  higher  doses  patch  formation  and  capping  were  seen.  At  still 
higher doses, rapid redistribution with prominent internalization was observed. 
The degree of redistribution  was also affected by time.  Even with  low doses, 
there was some patching and capping when incubations were prolonged to 220 
rnin. In general, redistribution appeared to be a direct function of concentration 
of anti-IgE, time, and temperature. 
In an attempt to understand the biological function of capping and patching 
in basophils,  we have studied the correlation between  the redistribution  of cell 
surface IgE and histamine  release.  In the anti-IgE induced histamine  release, 
previous  studies  have  shown  that  divalent  cations  are  necessary for the  bio- 
chemical processes following the antigen-antibody reaction on the cell surface to 
proceed (17). It has also been found that basophils from some individuals do not 
FIG.  2.  Photomicrographs  of basophils stained  with  different concentrations  of fluores- 
ceinated anti-IgE. Top row, diffuse labeling with Fab  t anti-IgE 10/zg/ml. Second row, patchy 
distribution  with F(ab').., anti-IgE 1-2/zg/mI.  Third  row, capping with (Fab)r2 anti-IgE 10- 
14/zg/ml.  Fourth row, last frame is microscopic field of the frame immediately above viewed 
with phase microscopy; first two frames demonstrate internalization.  Magnification: first row, 
frames 1 and 2, X  1980, last  frame X  990; second row  X  1980; third  row, first  frame  X 
990, last two frames X  1980; fourth row, first two frames X  990, last frame X  1980. FIo. 3.  Section of human basol)hil reacted with intact rabbit anti-IgE, hybrid antibody and 
ferritin at 37°C. Bound ferritin is distributed in a  dense patch or cap occupying less than one.- 
fourth of the cell membrane. X  40,0D0. 
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TABLE II 
Histamine Release and Surface  IgE Distribution  with Divalent Anti-IgE. 
Effect of Temperature  and  Concentration. 
Subject  Conc. a-IgE  Time  Temp  Histamine  Staining pattern 
release  Diff.  Patchy  Caps  Intern. 
gg/ml  rain  °C  % 
P.G.  0.14  30  0  0  100  0  0  0 
0.14"  30  37  74  98  2  0  0 
1.4  30  0  4  96  4  0  0 
1.4"  30  37  44  8  75  17  0 
14.0  30  0  0  18  76  6  0 
14.0"  30  37  10  2  38  59  0 
H.M.  26.0  30  0  0  56  40  4  0 
26.0  30  37  0  14  52  34  0 
* See Table I for complete data. 
IOO  o~ 
&  \m  Palchy  40 
/  ~  . 
2o  /1  '~'"" 
.  .~  "~  Histamine 
~  _a  /  13.... _~  Release 
Diffuse 
0.01  0.1  1.0  I0.0 
CONCENTRATION ANTI-IgE  (,u.g/ml) 
FIe. 4.  Histamine release and distribution  of cell surface IgE with different doses of divalent 
anti-IgE and incubations of 30 min at 37°C. All data are from an experiment involving cells 
from the same subject  (PG). 
release a significant amount of histamine even when antigen-antibody reactions 
occur on their surfaces (1), but release histamine if they are challenged by anti- 
IgE in the presence of D20  (6).  The present  experiments clearly showed that 
capping of cell-surface IgE occurs on such cells as the result of antigen-antibody 
reaction and  that  divalent cations  are  not  required for cap  formation.  It ap- 
pears  that  the  biochemical processes  regulating  the  later  stages  of histamine 
release are not involved in cap formation. 
Importantly,  for the purpose  of this study,  it appears  that  both histamine 
release and redistribution require divalent anti-IgE. Patching and capping were 
not observed with high doses of Fab' fragments of anti-IgE even with prolonged 406  SURFACE IgE  DURING HISTAMINE RELEASE 
TABLE III 
Histamine Release  and  Cell Su([ace  IgE Distribution with  Anligen  E 
Subject  Conc. antigen  Time  Temp  Histamine  Staining pattern 
release  Diff.  Patchy  Caps  Intern. 
~g/ml  rain  °C  5z, 
J.S.  0.0033*  40  37  75  100  0  0  0 
3.3  40  37  44  100  0  0  0 
0.0033*  120  37  51  100  0  0  0 
3.3  120  37  40  100  0  0  0 
B.W.  0.0002*  30  37  82§  100  0  0  0 
0.001  30  37  72§  100  0  0  0 
0.02  30  37  50§  100  0  0  0 
J.A.  0.001:~  30  0  5  100  0  0  0 
0.001 {  30  37  90  100  0  0  0 
* Optimum release with this dose. 
:~ Approximately 25 times optimum dose. 
§ Results from a separate experiment. 
incubations. In addition, histamine release did not occur with Fab' fragments 
unless very high concentrations were used, and histamine release was progres- 
sively less  as Fab' fractions were  successively purified by gel filtration. In  a 
previous study  (16)  there was no  significant histamine release with Fab frag- 
ments  obtained by papain digestion of anti-IgE.  That  we  have  slight release 
with  the  Fab' fragments  at high  concentrations  may  be  due  to  residual un- 
digested  antibody or  aggregated Fab' material.  It does  not  appear  that  low 
avidity of the  monovalent  anti-IgE is  the  reason  that  histamine  release and 
capping do not  occur,  since by fluorescence or  electronmicroscopy the mono- 
valent antibody stained the cells equally as well as divalent antibody used in the 
same concentrations. 
While the present studies were in progress, we were informed of the studies of 
Ferrarini et al.  (18).  These workers studied guinea pig basophil degranulation 
in the presence of antiguinea pig immunoglobulin. Their studies are somewhat 
different than  our own,  and  though  their conclusions are similar, the basis for 
these conclusions are somewhat  different.  First, it is uncertain  whether  their 
system primarily dealt with cell activation via IgG or IgE antibodies or both. 
More  important,  their  conclusion  that  redistribution  was  not  required  for 
histamine  release was  based  on  the  observation  that  monovalent  Fab' frag- 
ments  of  the  anti-Ig did  not  induce  observable  redislribution but  did  cause 
degranulation. As stated above, in previous studies (16) and in the present work, 
we  have  failed to  obtain significant histamine  release with  monovalent  frag- 
ments,  the  most  highly  purified  preparations showing  less  than  }{,000  the 
activity of the divalent antibody. It may be that the results of Ferrarini et al. in 
fact, are due to small amounts of aggregated Fab', and therefore correspond to 
those  experiments  in  which  we  used  low  doses of divalent antibady. Thus  it B:ECKER,  ISHIZAKA~ METZGER, ISHIZAKA, AND  GRIMLEY  407 
appears that bridging of the cell-surface IgE by divalent anti-IgE was required 
to initiate both the redistribution of IgE and histamine release. 
The present data clearly demonstrate that cap formation of surface IgE is not 
a prerequisite for histamine release. As shown in Fig. 4 and Table I, the dose 
and time dependence of redistribution and histamine release are quite different. 
Thus at lower doses of anti-IgE (0.1 ~g/ml), no redistribution is observed under 
conditions which  give maximal or near maximal  histamine  release. At  these 
doses histamine  release is completed long before redistribution  becomes sig- 
nificant.  Most notably,  those doses which  redistribute the  surface IgE  most 
effectively (10-14 #g/ml) in fact cause marked inhibition of histamine release. 
One might have supposed that the failure to induce histamine release at high 
doses of anti-IgE was due to the  formation of 1:1  anti-IgE:IgE complexes in 
which  the  requirement for bridging  of surface IgE  would  not  be  met.  The 
present experiments clearly show that this is not the case since at such high doses 
cap formation (which also  requires bridging  of surface IgE) does take place. 
These results appear to indicate that only certain kinds of bridging of surface 
IgE are effective in causing histamine release. 
There are some parallels between our results on surface IgE on basophils and 
studies concerning immunoglobulins on lymphocytes. Taylor et al.  (19)  have 
shown that mouse spleen cells reacted with antimouse immunoglobulin demon- 
strated capping when incubated at 37°C  for short periods. In  addition  they 
found that capping was not affected by the presence or absence of Ca  ++ and 
Mg  ++, and that Fab' fragments of the anti-Ig did not induce capping. Edidin 
and Weiss (20) using cultured fibroblasts have found that capping was induced 
in the presence of antibody to H2 histocompatibility antigens if the cells were 
incubated at 37°C. Loor et al.  (21)  using mouse spleen cells have also found 
capping in the presence of intact F(ab')., of anti-Ig but not in the presence of 
Fab p fragments from such antibodies. They found a  similar temperature de- 
pendence on cap formation. Finally, Unanue, Karnovsky, and coworkers (22, 
23) have demonstrated that  the movement of cell surface immunoglobulin is 
sensitive  to  the  concentration of anti-Ig.  They demonstrated cap formation 
within 5 rain, when a high concentration of anti-Ig was used. Relatively slower 
rates of cap formation on basophils in the present experiments may be due to 
slightly smaller number of IgE molecules on basophils.  Rabellino et al.  (24), 
reported  10  ~ Ig  molecules  per  B  lymphocyte, whereas  the  number  of  IgE 
molecules per basophil has been estimated to be 10,000-30,000  (2, 6). Failure 
of visible cap  formation by ragweed  allergen  may also  be  due  to  a  smaller 
number of reactive IgE antibody molecules, relative to the total surface IgE. 
All of these results support a model of the cell membrane which permits move- 
ment of protein in the plane of the membrane (25). 
SUMMARY 
The distribution of surface IgE on human basophils was studied using fluores- 
cence microscopy and immunoferritin electronmicroscopy. Redistribution of the 408  SURFACE IgE DURING HISTAMINE RELEASE 
IgE was dose, time and temperature dependent and required divalent anti-IgE. 
Cells  which can  release  histamine  in vitro were indistinguishable  in  these  re- 
spects from cells which cannot. The redistribution  was unaffected by the pres- 
ence or absence of Ca  ++. 
No correlation between the conditions required for optimal histamine release 
and for redistribution  was  observed.  At low doses,  optimal  histamine  release 
occurred in the absence of, or before, redistribution.  At higher doses redistribu- 
tion occurred in  the  absence of histamine  release.  Antigen-induced histamine 
release was unaccompanied by gross redistribution of the surface IgE. 
Since both  histamine  release  and  redistribution  require  bridging of IgE on 
basophils  it  is  concluded  that  only certain  kinds  of cross-linking  of the  IgE 
effectively stimulates  these cells. 
The authors thank Miss Sharon Mims for valuable technical assistance. 
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